CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −12,711 | $63.95 | $813K | 173,904 |
| 2026-01-05 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −1,200 | $64.49 | $77K | 172,704 |
| 2026-01-05 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −437 | $65.97 | $29K | 172,267 |
| 2026-01-05 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −309 | $68.00 | $21K | 171,958 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −4,368 | $61.20 | $267K | 520,033 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −6,164 | $62.23 | $384K | 513,869 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −13,451 | $62.96 | $847K | 500,418 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −11,842 | $63.84 | $756K | 488,576 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −2,700 | $64.44 | $174K | 485,876 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −900 | $66.01 | $59K | 484,976 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −313 | $68.00 | $21K | 484,663 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −600 | $61.12 | $37K | 484,063 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −900 | $62.25 | $56K | 483,163 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −5,873 | $62.91 | $369K | 477,290 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −2,336 | $64.04 | $150K | 474,954 |
| 2026-01-05 | O'Brien Patrick COO | Sale 10b5-1 | −46 | $68.00 | $3K | 474,908 |
| 2026-01-02 | Anzalone Christopher Richard Chief Executive Officer | Sale 10b5-1 | −7,416 | $65.88 | $489K | 3,798,510 |
| 2026-01-02 | Anzalone Christopher Richard Chief Executive Officer | Sale 10b5-1 | −5,771 | $66.39 | $383K | 3,792,739 |
| 2025-12-31 | O'Brien Patrick COO | Gift 10b5-1 | −560 | 526,641 | ||
| 2025-12-31 | O'Brien Patrick COO | Gift 10b5-1 | −560 | 526,081 |
Page 2 of 28 · 542 trades